Keyphrases
Intraocular Pressure
94%
Mitomycin C
59%
Trabeculectomy
52%
Randomized Clinical Trial
47%
Glaucoma
43%
Primary Open-angle Glaucoma
43%
Ahmed Glaucoma Valve Implantation
42%
Best-corrected Visual Acuity
30%
Central Corneal Thickness
26%
Primary Congenital Glaucoma
26%
Glaucoma Patients
26%
Glaucoma Medication
25%
Photorefractive Keratectomy
23%
Yazd
23%
Visual Acuity
23%
Intraocular Pressure Reduction
21%
Compound Trabeculectomy
21%
Peripapillary Retinal Nerve Fiber Layer (pRNFL)
20%
Success Rate
20%
Axial Length
18%
Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
18%
Pseudoexfoliation Syndrome
18%
Ahmed Glaucoma Valve
18%
Primary Angle Closure Suspect
17%
Keratoconus
17%
Recent-onset
17%
Erythropoietin
17%
Glaucomatous
17%
Neovascular Glaucoma
15%
Anterior Chamber Depth
14%
Normal Eyes
14%
CYP1B1 mutations
13%
Aphakic Glaucoma
13%
Intravitreal Bevacizumab
13%
Cornea
13%
Phacoemulsification
13%
Non-contact
12%
Methanol-induced Optic Neuropathy
12%
Corneal Densitometry
12%
Refractory Glaucoma
11%
Trabeculectomy with Mitomycin C
11%
Fellow Eye
11%
Optic Disc
10%
Corneal Biomechanics
10%
Cup-to-disc Ratio
10%
Intraocular Pressure Measurement
10%
Meta-analysis
10%
Randomized Controlled Trial
10%
Laser Peripheral Iridotomy
10%
Ocular Biometrics
10%
Medicine and Dentistry
Intraocular Pressure
100%
Glaucoma
90%
Trabeculectomy
71%
Mitomycin
64%
Glaucoma Valve
47%
Randomized Clinical Trial
41%
Open Angle Glaucoma
32%
Anterior Chamber of Eyeball
29%
Biometry
28%
Best Corrected Visual Acuity
27%
Retinal Nerve Fiber Layer
25%
Visual Acuity
24%
Glaucoma Medication
21%
Congenital Glaucoma
20%
Arteritic Anterior Ischemic Optic Neuropathy
18%
Photorefractive Keratectomy
18%
Phacoemulsification
18%
Optical Coherence Tomography
18%
Pseudoexfoliation
16%
Prevalence
16%
Disease
15%
Neovascular Glaucoma
15%
Optic Neuropathy
14%
Visual Impairment
14%
Erythropoietin
13%
Bevacizumab
13%
Keratoconus
13%
Pediatrics
13%
Drug Therapy
13%
Optic Disc
13%
Implant
12%
Iridotomy
12%
Optic Nerve
11%
Cup-to-Disc Ratio
11%
Endothelial Cell
11%
Visual Field
10%
Subtenon Drug Administration
9%
Odds Ratio
9%
Closed Angle Glaucoma
9%
Fasudil
9%
Corneal Dystrophy
9%
Radial Keratotomy
9%
Free Tissue Graft
9%
Optic Neuritis
9%
CYP1B1
9%
Methanol
9%
Agents Acting on the Eye
8%
Glaucoma Surgery
8%
Cataract Surgery
8%
Densitometry
7%